Keros Therapeutics Inc (NASDAQ: KROS): Do Not Miss The Gain Train
Keros Therapeutics Inc (KROS) concluded trading on Wednesday at a closing price of $10.42, with 13.6 million shares of worth about $141.7 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -80.03% during that period and on January 15, 2025 the price saw a […]
Keros Therapeutics Inc (NASDAQ: KROS): Reassessing Prospects
Keros Therapeutics Inc (KROS) concluded trading on Thursday at a closing price of $18.43, with 14.61 million shares of worth about $269.25 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -62.77% during that period and on December 12, 2024 the price saw a […]
